Zoetis (ZTS) Reaches New Lifetime High Today

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified Zoetis ( ZTS) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Zoetis as such a stock due to the following factors:

  • ZTS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $79.8 million.
  • ZTS has traded 15,172 shares today.
  • ZTS is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ZTS with the Ticky from Trade-Ideas. See the FREE profile for ZTS NOW at Trade-Ideas

More details on ZTS:

Zoetis Inc. is engaged in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals worldwide. It operates through four segments: United States, Europe/Africa/Middle East, Canada/Latin America, and Asia/Pacific.

The average volume for Zoetis has been 3.3 million shares per day over the past 30 days. Zoetis has a market cap of $15.9 billion and is part of the health care sector and drugs industry.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
null

If you liked this article you might like

These Stocks Have Changed Direction

Investors Need to Closely Watch Mario Draghi's Speech at Jackson Hole: Market Recon

Who's Afraid of the Amazon Empire?: Cramer's 'Mad Money' Recap (Thursday 6/22/17)

Citigroup, Zoetis, AbbVie, Mattel, Valeant Pharmaceuticals 'Mad Money' Lightning Round

Zoetis: Cramer's Top Takeaways